Michael R. Hodges - Concepedia

Author

Michael R. Hodges

Amplyx Pharmaceuticals (United States)ORCID

Also Known As

Hodges, Michael, M Hodges, M R Hodges, M. HODGES, M. Hodges, M. R. HODGES, M. R. Hodges, M.R. HODGES, M.R. Hodges, M. R. Hodges

Publications

8.3K

Citations

H-Index

101

Concepts

All Affiliations

Amplyx Pharmaceuticals (United States)Pfizer (United States)University of Utah Florida College Erasmus MC

About

Michael R. Hodges is an author at Amplyx Pharmaceuticals (United States) specializing in medicine, anesthesiology, and anesthesia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.3K
2	Public Health	3	3	43
3	Health Sciences	2	2	27
4	Education	1	1	10
5	Engineering	1	1	10

Michael R. Hodges

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis Raoul Herbrecht, David W. Denning, Thomas F. Patterson, New England Journal of Medicine	2002	3.3K
Treatment of HCV Infection by Targeting MicroRNA Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz, New England Journal of Medicine	2013	2.2K
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children Thomas J. Walsh, Irja Lutsar, Timothy Driscoll, The Pediatric Infectious Disease Journal	2002	435
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients R. Ally, Dirk Schürmann, Wolfgang Kreisel, Clinical Infectious Diseases Diagnostic MycologyAnti-infective AgentsAntifungal AgentAntifungal AgentsBiopsy-proven Esophageal Candidiasis	2001	333
<i>In Vitro</i> Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122 Søren Ottosen, Todd B. Parsley, Lu Yang, Antimicrobial Agents and Chemotherapy	2014	228
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients Meike H. van der Ree, Joep de Bruijne, Raoel Maan, Antiviral Research HepatologyHepatitis CViral HepatitisImmunologyHepatitis	2014	190
Ventilatory Pattern, Interpleural Pressure, and Cardiac Output John B. Downs, MICHAL E. DOUGLAS, Peter M. Sanfelippo, Anesthesia & Analgesia	1977	104
Sildenafil citrate (viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects W W Dinsmore, Michael R. Hodges, Claire Hargreaves, Urology AndrologyUrologyErectile DysfunctionBroad-spectrum Erectile DysfunctionSexual Dysfunction	1999	104
Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9 Eveline P. van Poelgeest, Reinout M. Swart, Michiel G.H. Betjes, American Journal of Kidney Diseases UrologyMedicineKidney FailureImmunologyCell Death	2013	88
Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial Eveline P. van Poelgeest, Michael R. Hodges, Matthijs Moerland, British Journal of Clinical Pharmacology	2015	87

Page 1